
Amineo provides custom protein design services to accelerate the development of safer, more effective biomolecules. The company blends the team’s expertise with a proprietary design platform to tailor enzymes, antibodies, nano-antibodies, macromolecular assemblies, and peptides. Its services cover improved, modified, or new proteins aimed at enhancing specificity, stability, and solubility. By streamlining design work, Amineo seeks to shorten development timelines and reduce costs for high-impact biomolecules. The business targets biotech and pharmaceutical developers, with activity launching in 2025.

Amineo provides custom protein design services to accelerate the development of safer, more effective biomolecules. The company blends the team’s expertise with a proprietary design platform to tailor enzymes, antibodies, nano-antibodies, macromolecular assemblies, and peptides. Its services cover improved, modified, or new proteins aimed at enhancing specificity, stability, and solubility. By streamlining design work, Amineo seeks to shorten development timelines and reduce costs for high-impact biomolecules. The business targets biotech and pharmaceutical developers, with activity launching in 2025.